Generic Drugs Market Size, Share, Growth, Geography, Recent Developments, Strategic Insights 2031

The Generic Drugs Market size is projected to reach USD 594.99 billion by 2031 from USD 423.55 billion in 2024. The market is expected to register a CAGR of 5.0% during 2025–2031. The rising popularity of biosimilars is likely to bring new trends in the generic drugs market in the coming years.

Download PDF Copy: https://www.theinsightpartners.com/sample/TIPRE00003414

North America is expected to dominate the generic drugs market during the forecast period, and Asia Pacific is expected to register significant growth owing to rising healthcare needs, cost-conscious government policies, and increasing demand for affordable treatment options. China and India lead in manufacturing, Japan and South Korea focus on innovation, while Australia sees growing biotech investments, collectively fuelling market expansion.

Generic Drugs Market Segmentation:

By Molecule Type

Antidepressants
Antihistamines
Analgesics
Antibiotics
Antivirals
Diuretics

By Indication

Metabolic Diseases
Cancer
Immunology
Respiratory Disorder
Cardiovascular Disorder
Neurology Disorder
Rare Disease

By Type

Prescription
OTC Drugs

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Top Market Leaders:

Teva Pharmaceutical Industries Ltd
Viatris Inc
Dr. Reddy’s Laboratories Ltd
Novartis AG
Sun Pharmaceutical Industries Ltd
AbbVie Inc
AstraZeneca Plc
Sanofi SA
Aurobindo Pharma Ltd
Glenmark Pharmaceuticals Ltd.

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.